Gavin Yamey | |
---|---|
Academic background | |
Education | BA, physiological sciences/medicine, University of Oxford MBBS, 1994, University College London MRCP (UK), 1994, Royal College of Physicians MPH, 2010, London School of Hygiene & Tropical Medicine |
Academic work | |
Institutions | Duke University University of California,San Francisco UCSF School of Medicine |
Gavin Mark Yamey is a British-American physician and global health researcher. He is the director of the Center for Policy Impact in Global Health at Duke University and a professor of the practice of global health and public policy.
Yamey earned his Bachelor of Arts degree in physiological sciences/medicine from the University of Oxford, [1] his Bachelor of Medicine and Bachelor of Surgery (MBBS) from University College London in 1994 and his Master of Public Health from the London School of Hygiene &Tropical Medicine in 2010. [2] Upon receiving his MBBS,Yamey worked in a variety of London teaching hospitals and completed his public health training at the London School of Hygiene and Tropical Medicine. He finished his medical training at Oxford University and University College London,qualifying as a physician in 1994 and becoming a member of the Royal College of Physicians in 1997. [1]
Yamey moved to San Francisco in 2001 to become the deputy editor of the Western Journal of Medicine while also remaining an assistant editor for The BMJ . By 2004,he was appointed as a founding senior editor of PLOS Medicine and was the principal investigator on a grant from the Bill &Melinda Gates Foundation to support the launch of PLOS Neglected Tropical Diseases . [1] A few years later,Yamey received a Kaiser Family Foundation Mini-Fellowship in Global Health Reporting to write a series of news features and editorials on scaling up low-cost,low-technology health tools in East Africa. [3] As a professor at the UCSF School of Medicine,Yamey served on two international health commissions,the Lancet Commission on Investing in Health and the Lancet Commission on Global Surgery,and led the writing of "Global Health 2035" which was published on December 3,2013. [1] He was also a co-author on a report titled "Global Surgery 2030:A Roadmap for High-Income Country Actors",which arose from the Lancet Commission on Global Surgery,and which was meant to be used as a roadmap to expand access to surgical care around the world. [4] [5]
In 2015,Yamey joined the Duke University Global Health Institute faculty as a professor of the practice of global health and public policy. and an associate director in the Institute responsible for leading a global health policy initiative. While serving in this role,he was also appointed professor of public policy in the Duke Sanford School of Public Policy. [6] In December 2016,he became the director of the newly established Center for Policy Impact in Global Health at Duke. [7] Yamey followed this up by presenting the "Investing in Health:The Economic Case" at the World Innovation Summit for Health to promote investing in cost-effective health interventions. [8]
As the director of the Center for Policy Impact in Global Health,Yamey and his research team address questions in global health,particularly related to its financing,governance,architecture and delivery. In 2018,the Center team used the Portfolio-to-Impact (P2I),a financial modeling tool,to analyze candidate medicines,vaccines,diagnostics and other technologies for neglected diseases at various stages of development in an effort to calculate the costs of developing these products. [9]
Prior to the COVID-19 pandemic,Yamey published an op-ed titled "The Odds of a Devastating Pandemic Just Went Up" which was critical of Trump administration's decision to scale back investments for pandemic prevention and response. [10] Once the pandemic hit,Yamey collaborated with researchers to co-author "Ensuring global access to COVID-19 vaccines",which listed suggestion on how to best deploy the vaccine to the population. [11] As a result,he also worked alongside David McAdams and the World Health Organization to map out strategies for deploying an effective COVID-19 vaccine worldwide. [12] Beyond Duke,Yamey is a columnist for Time magazine where he has written articles on the United States' response to COVID-19. [13]
Global health is the health of the populations in the worldwide context;it has been defined as "the area of study,research,and practice that places a priority on improving health and achieving equity in health for all people worldwide". Problems that transcend national borders or have a global political and economic impact are often emphasized. Thus,global health is about worldwide health improvement,reduction of disparities,and protection against global threats that disregard national borders,including the most common causes of human death and years of life lost from a global perspective.
Peter Jay Hotez is an American scientist,pediatrician,and advocate in the fields of global health,vaccinology,and neglected tropical disease control. He serves as founding dean of the National School of Tropical Medicine,Professor of Pediatrics and Molecular Virology &Microbiology at Baylor College of Medicine,where he is also Director of the Texas Children's Hospital Center for Vaccine Development and Texas Children's Hospital Endowed Chair in Tropical Pediatrics,and University Professor of Biology at Baylor College of Medicine. Hotez served previously as president of the American Society of Tropical Medicine and Hygiene and is a founding Editor-in-Chief of PLOS Neglected Tropical Diseases. He is also the co-director of Parasites Without Borders,a global nonprofit organization with a focus on those suffering from parasitic diseases in subtropical environments.
Muhammad Ali Pate CON is a Nigerian physician and politician who is Professor of the Practice of Public Health Leadership in the Department of Global Health and Population at Harvard University. He formerly served as the Global Director for Health,Nutrition and Population and Director of the Global Financing Facility for Women,Children and Adolescents (GFF) at the World Bank Group. Pate is also the former Minister of State for Health in Nigeria.
Agnes Binagwaho is a Rwandan pediatrician and co-founder and the former vice chancellor of the University of Global Health Equity (2017-2022). In 1996,she returned to Rwanda where she provided clinical care in the public sector as well as held many positions including the position of Permanent Secretary for the Ministry of Health of Rwanda from October 2008 until May 2011 and Minister of Health from May 2011 until July 2016. She has been a Professor of Global Health Delivery Practice since 2016 and a Professor of Pediatrics since 2017 at the University of Global Health Equity. She resides in Kigali.
Martin Adel Makary is a British-American surgeon,professor,author and medical commentator. He practices surgical oncology and gastrointestinal laparoscopic surgery at the Johns Hopkins Hospital,is Mark Ravitch Chair in Gastrointestinal Surgery at Johns Hopkins School of Medicine,and teaches public health policy as Professor of Surgery and Public Health at the Johns Hopkins Bloomberg School of Public Health.
Salim S. Abdool Karim,MBChB,MMed,MS(Epi),FFPHM,FFPath (Virol),DipData,PhD,DSc(hc) is a South African public health physician,epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment,saving thousands of lives
Gagandeep Kang FRS is an Indian Microbiologist and virologist who is the Professor in the Department of Gastrointestinal Sciences at the Christian Medical College,Vellore,India and from August 2016 to July 2020 was executive director of the Translational Health Science and Technology Institute,Faridabad,an autonomous institute of the Department of Biotechnology,Ministry of Science and Technology,Government of India. She is a leading researcher with a major research focus on viral infections in children,and the testing of rotaviral vaccines. She also works on other enteric infections and their consequences when children are infected in early life,sanitation and water safety. She was awarded the prestigious Infosys Prize in Life Sciences in 2016 for her contributions to understanding the natural history of rotavirus and other infectious diseases. In 2019,she became the first Indian woman to be elected as a Fellow of the Royal Society. She was on the Life Sciences jury for the Infosys Prize in 2020.
Ashish Kumar Jha is an Indian-American general internist physician and academic serving as the White House COVID-19 Response Coordinator. He is currently on a short-term leave from the Brown University School of Public Health where he served as the Dean. Prior to Brown,he was the K.T. Li Professor of Global Health at Harvard T.H. Chan School of Public Health,faculty director of the Harvard Global Health Institute,and a Senior Advisor at Albright Stonebridge Group. Jha is recognized as one of the leading health policy scholars in the nation. Jha's role at Brown University focuses on improving the quality and cost of health care,and on the impact of public health policy.
Heidi J. Larson is an American anthropologist and the founding director of the Vaccine Confidence Project. Larson headed Global Immunisation Communication at UNICEF and she is the author of Stuck:How Vaccine Rumors Start and Why They Don't Go Away. She was recognized as one of the BBC's 100 women of 2021.
Michele Barry is a professor of medicine. She became Stanford's inaugural Senior Associate Dean of global health in 2009 and started the Stanford Center for Innovation in Global Health in 2010. Prior to this,she was a professor at Yale,where she started the first refugee health clinic and homeless health mobile van project,for which she was awarded the Elm Ivy Mayor’s Award. She specializes in tropical medicine,emerging infectious diseases,women’s leadership in global health,and human and planetary health.
Devi Lalita Sridhar FRSE is an American public health researcher,who is both professor and chair of global public health at the University of Edinburgh,Scotland. Her research considers the effectiveness of public health interventions and how to improve developmental assistance for health. Sridhar directs the University of Edinburgh's Global Health Governance Programme which she established in 2014.
Dave Ashok Chokshi is an American physician and former public health official who served as the 43rd health commissioner of New York City. He is the first health commissioner of Asian descent. Chokshi previously served as the inaugural chief population health officer for NYC Health + Hospitals and as a White House fellow in the United States Department of Veterans Affairs.
Shabir Ahmed Madhi is a South African physician who is professor of vaccinology and director of the South African Medical Research Council Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand,and National Research Foundation/Department of Science and Technology Research Chair in Vaccine Preventable Diseases. In January 2021,he was appointed Dean of the Faculty of Health Sciences at the University of the Witwateratand.
Louise Catherine Ivers is an Irish-American infectious disease specialist. She is the executive director of the Massachusetts General Hospital Center for Global Health and Professor of Medicine at Harvard Medical School. During the 2010s Haiti cholera outbreak,Ivers led a major humanitarian and public health response,resulting in increased access to HIV and TB treatment,and served as a technical advisor to the World Health Organization.
Geeta Krishna Swamy is an American OBGYN. She is a professor of obstetrics and gynecology at Duke University and Associate Vice President for Research and Vice Dean for Scientific Integrity.
Samba Ousemane Sow is a Malian physician who is Director General of the Centre pour les Vaccins en Développement and adjunct professor of medicine at the University of Maryland School of Medicine. He has been involved with Mali's public health effort against ebola,COVID-19 and leprosy. In 2021 he was elected an International Fellow of the National Academy of Medicine.
Vaccine equity means ensuring that everyone in the world has equal access to vaccines. The importance of vaccine equity has been emphasized by researchers and public health experts during the COVID-19 pandemic but is relevant to other illnesses and vaccines as well. Historically,world-wide immunization campaigns have led to the eradication of smallpox and significantly reduced polio,measles,tuberculosis,diphtheria,whooping cough,and tetanus.
Nina Schwalbe is an American public health researcher who is the founder of Spark Street Advisors,a public health think tank based in New York City. Schwalbe specializes in vaccines. She has previously worked at Gavi,UNICEF and USAID.
Julie Bines,is a clinician and researcher working in Melbourne,Australia. Alongside being a professor and deputy head of the Department of Paediatrics at the University of Melbourne,she is also a paediatric gastroenterologist at the Royal Children's Hospital Melbourne and is the leader of the Enteric Diseases group at the Murdoch Children's Research Institute. Bines is the joint head of the WHO Collaborative Centre for Child Health and founding member of Women in Global Health Australia.
Fatima Hassan is a South African human rights lawyer who works in the field of health justice.